NZ595231A - Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use - Google Patents
Polypeptides and immunizing compositions containing gram positive polypeptides and methods of useInfo
- Publication number
- NZ595231A NZ595231A NZ595231A NZ59523110A NZ595231A NZ 595231 A NZ595231 A NZ 595231A NZ 595231 A NZ595231 A NZ 595231A NZ 59523110 A NZ59523110 A NZ 59523110A NZ 595231 A NZ595231 A NZ 595231A
- Authority
- NZ
- New Zealand
- Prior art keywords
- amino acid
- polypeptides
- amino acids
- seq
- complete specification
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 8
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 8
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 8
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000003053 immunization Effects 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 abstract 12
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 4
- 238000012986 modification Methods 0.000 abstract 4
- 230000004048 modification Effects 0.000 abstract 4
- OEUUFNIKLCFNLN-LLVKDONJSA-N chembl432481 Chemical compound OC(=O)[C@@]1(C)CSC(C=2C(=CC(O)=CC=2)O)=N1 OEUUFNIKLCFNLN-LLVKDONJSA-N 0.000 abstract 2
- 238000012217 deletion Methods 0.000 abstract 2
- 230000037430 deletion Effects 0.000 abstract 2
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 238000006467 substitution reaction Methods 0.000 abstract 2
- 241000191940 Staphylococcus Species 0.000 abstract 1
- 241000191967 Staphylococcus aureus Species 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/38—Antigens from snakes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ61455710A NZ614557A (en) | 2009-03-23 | 2010-03-23 | Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21077209P | 2009-03-23 | 2009-03-23 | |
| PCT/US2010/028326 WO2010111273A1 (en) | 2009-03-23 | 2010-03-23 | Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ595231A true NZ595231A (en) | 2014-03-28 |
Family
ID=42781438
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ595231A NZ595231A (en) | 2009-03-23 | 2010-03-23 | Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use |
| NZ61455710A NZ614557A (en) | 2009-03-23 | 2010-03-23 | Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ61455710A NZ614557A (en) | 2009-03-23 | 2010-03-23 | Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US9932373B2 (enExample) |
| EP (1) | EP2411046B1 (enExample) |
| JP (2) | JP2012521441A (enExample) |
| KR (4) | KR101770321B1 (enExample) |
| CN (1) | CN105582524A (enExample) |
| AR (1) | AR075933A1 (enExample) |
| AU (1) | AU2016201992B2 (enExample) |
| BR (1) | BRPI1011856A2 (enExample) |
| CA (1) | CA2756313A1 (enExample) |
| IL (2) | IL215330A (enExample) |
| MX (1) | MX339461B (enExample) |
| NZ (2) | NZ595231A (enExample) |
| WO (1) | WO2010111273A1 (enExample) |
| ZA (1) | ZA201106959B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0607323B8 (pt) | 2005-02-14 | 2021-05-25 | Epitopix Llc | composições, usos de polipeptídeos e de anticorpos, bem como kits para a detecção de anticorpo que se liga especificamente a um polipeptídeo |
| BRPI1011856A2 (pt) | 2009-03-23 | 2020-11-03 | Epitopix, Llc | polipeptídeos e composições de imunização contendo polipeptídeos gram-positivos e métodos de uso |
| AU2013202253B2 (en) * | 2009-04-14 | 2015-03-19 | Novartis Ag | Compositions for immunising against Staphylococcus aureus |
| US9724658B2 (en) * | 2011-03-28 | 2017-08-08 | Fast & Fluid Management B.V. | Method of homogenizing a liquid |
| US8753643B1 (en) | 2012-04-11 | 2014-06-17 | Life-Science Innovations, Llc | Spray dried compositions and methods of use |
| US20170023569A1 (en) * | 2014-01-10 | 2017-01-26 | University Of Rochester | Diagnostic device and method for detection of staphylococcus infection |
| CA2991907A1 (en) * | 2015-07-10 | 2017-01-19 | Douglas T. Burkhardt | Proteins and immunizing compositions containing klebsiella proteins and methods of use |
| TW201819402A (zh) | 2016-10-21 | 2018-06-01 | 加拿大商索克普拉科學與工程公司 | 對抗葡萄球菌感染之疫苗構築體及其用途 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4981685A (en) | 1986-03-07 | 1991-01-01 | Utah State University Foundation | Bacterial extract vaccines for veterinary application |
| US5554372A (en) | 1986-09-22 | 1996-09-10 | Emory University | Methods and vaccines comprising surface-active copolymers |
| US5292869A (en) | 1989-04-27 | 1994-03-08 | The Board Of Governors Of The University | Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same |
| US5830479A (en) | 1994-02-09 | 1998-11-03 | Willmar Poultry Company, Inc. | Active immunization using a siderophore receptor protein |
| CA2182976C (en) | 1994-02-09 | 2011-07-12 | Daryll A. Emery | Active immunization using a siderophore receptor protein |
| US5538733A (en) | 1994-07-07 | 1996-07-23 | Willmar Poultry Company, Inc. | Method of priming an immune response in a one-day old animal |
| US6403337B1 (en) | 1996-01-05 | 2002-06-11 | Human Genome Sciences, Inc. | Staphylococcus aureus genes and polypeptides |
| WO1997043314A2 (en) | 1996-05-16 | 1997-11-20 | The Texas A & M University System | Collagen binding protein compositions and methods of use |
| US6680195B1 (en) | 1997-11-26 | 2004-01-20 | Inhibitex, Inc. | Extracellular matrix-binding proteins from staphylococcus aureus |
| US6692739B1 (en) | 1998-08-31 | 2004-02-17 | Inhibitex, Inc. | Staphylococcal immunotherapeutics via donor selection and donor stimulation |
| US6703025B1 (en) | 1998-08-31 | 2004-03-09 | Inhibitex, Inc. | Multicomponent vaccines |
| US6682754B2 (en) | 1999-11-24 | 2004-01-27 | Willmar Poultry Company, Inc. | Ovo delivery of an immunogen containing implant |
| EP1268774A2 (en) * | 2000-03-21 | 2003-01-02 | Elitra Pharmaceuticals, Inc. | Identification of essential genes in prokaryotes |
| AT410173B (de) | 2000-06-08 | 2003-02-25 | Cistem Biotechnologies Gmbh | Antigene zusammensetzung |
| WO2002053180A2 (en) | 2001-01-03 | 2002-07-11 | Willmar Poultry Company, Inc. | Immunizing compositions and methods of use |
| AT410798B (de) * | 2001-01-26 | 2003-07-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen |
| GB0107661D0 (en) * | 2001-03-27 | 2001-05-16 | Chiron Spa | Staphylococcus aureus |
| EP2320233A1 (en) | 2001-06-15 | 2011-05-11 | Inhibitex, Inc. | Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| AU2002353764A1 (en) | 2001-06-17 | 2003-03-18 | D-Squared Biotechnologies, Inc. | Staphylococci surface-exposed immunogenic polypeptides |
| US6720160B2 (en) | 2001-10-11 | 2004-04-13 | Helica Biosystems, Inc. | Method for simultaneous detection of multiple microbial antigens in biological specimens from mastitic animals |
| AU2003254555A1 (en) | 2002-07-26 | 2004-02-23 | Intercell Ag | S. aureus antigene |
| BRPI0414267A (pt) | 2003-09-19 | 2006-11-21 | Epitopix Llc | polipeptìdeos de campilobacter e métodos de uso |
| WO2005103073A2 (en) | 2004-04-27 | 2005-11-03 | Intercell Ag | Td antigens |
| EP1784220B1 (en) | 2004-08-26 | 2017-12-20 | The University Of Western Ontario | Bacterial iron acquisition targets |
| CA2581746A1 (en) * | 2004-10-25 | 2006-06-08 | The University Of Western Ontario | Staphylococcus aureus isd protein-based anti-infectives |
| BRPI0607323B8 (pt) | 2005-02-14 | 2021-05-25 | Epitopix Llc | composições, usos de polipeptídeos e de anticorpos, bem como kits para a detecção de anticorpo que se liga especificamente a um polipeptídeo |
| US8021885B2 (en) | 2006-10-11 | 2011-09-20 | Evonik Rohmax Additives Gmbh | Method for the determination of the oxidative stability of a lubricating fluid |
| BRPI1011856A2 (pt) | 2009-03-23 | 2020-11-03 | Epitopix, Llc | polipeptídeos e composições de imunização contendo polipeptídeos gram-positivos e métodos de uso |
-
2010
- 2010-03-23 BR BRPI1011856-0A patent/BRPI1011856A2/pt not_active Application Discontinuation
- 2010-03-23 NZ NZ595231A patent/NZ595231A/en not_active IP Right Cessation
- 2010-03-23 KR KR1020167013476A patent/KR101770321B1/ko not_active Expired - Fee Related
- 2010-03-23 CN CN201510958692.5A patent/CN105582524A/zh active Pending
- 2010-03-23 US US13/142,524 patent/US9932373B2/en active Active
- 2010-03-23 MX MX2011009949A patent/MX339461B/es active IP Right Grant
- 2010-03-23 JP JP2012502164A patent/JP2012521441A/ja not_active Withdrawn
- 2010-03-23 EP EP10756718.2A patent/EP2411046B1/en active Active
- 2010-03-23 KR KR1020167026534A patent/KR20160114744A/ko not_active Ceased
- 2010-03-23 WO PCT/US2010/028326 patent/WO2010111273A1/en not_active Ceased
- 2010-03-23 CA CA2756313A patent/CA2756313A1/en active Pending
- 2010-03-23 KR KR1020117025065A patent/KR20120005471A/ko not_active Ceased
- 2010-03-23 KR KR1020157018079A patent/KR101684292B1/ko not_active Expired - Fee Related
- 2010-03-23 NZ NZ61455710A patent/NZ614557A/en not_active IP Right Cessation
- 2010-03-25 AR ARP100100938A patent/AR075933A1/es unknown
-
2011
- 2011-09-22 IL IL215330A patent/IL215330A/en not_active IP Right Cessation
- 2011-09-22 ZA ZA2011/06959A patent/ZA201106959B/en unknown
-
2015
- 2015-05-13 JP JP2015098351A patent/JP6092933B2/ja active Active
-
2016
- 2016-03-30 AU AU2016201992A patent/AU2016201992B2/en not_active Ceased
- 2016-10-26 IL IL248523A patent/IL248523A0/en unknown
-
2018
- 2018-04-02 US US15/943,214 patent/US20180237481A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20180237481A1 (en) | 2018-08-23 |
| KR101684292B1 (ko) | 2016-12-08 |
| AU2010229498A1 (en) | 2011-10-13 |
| BRPI1011856A2 (pt) | 2020-11-03 |
| EP2411046A1 (en) | 2012-02-01 |
| EP2411046B1 (en) | 2017-12-06 |
| CN105582524A (zh) | 2016-05-18 |
| US9932373B2 (en) | 2018-04-03 |
| IL248523A0 (en) | 2016-12-29 |
| CN102448489A (zh) | 2012-05-09 |
| IL215330A (en) | 2016-12-29 |
| AU2016201992B2 (en) | 2018-02-15 |
| KR20160064237A (ko) | 2016-06-07 |
| KR20160114744A (ko) | 2016-10-05 |
| EP2411046A4 (en) | 2012-09-19 |
| KR101770321B1 (ko) | 2017-09-05 |
| JP2012521441A (ja) | 2012-09-13 |
| US20120034258A1 (en) | 2012-02-09 |
| MX339461B (es) | 2016-05-27 |
| JP2015164949A (ja) | 2015-09-17 |
| AU2016201992A1 (en) | 2016-04-21 |
| CA2756313A1 (en) | 2010-09-30 |
| KR20150093774A (ko) | 2015-08-18 |
| WO2010111273A1 (en) | 2010-09-30 |
| NZ614557A (en) | 2015-03-27 |
| KR20120005471A (ko) | 2012-01-16 |
| JP6092933B2 (ja) | 2017-03-08 |
| AR075933A1 (es) | 2011-05-04 |
| MX2011009949A (es) | 2011-10-06 |
| ZA201106959B (en) | 2012-06-27 |
| IL215330A0 (en) | 2011-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ595231A (en) | Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use | |
| NZ603811A (en) | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases | |
| PH12012501831B1 (en) | Protein ipa1 related to plant architecture, its coding genes and uses | |
| NZ602845A (en) | Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof | |
| MX340014B (es) | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. | |
| MX2012008998A (es) | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. | |
| MX2012009000A (es) | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. | |
| NZ598351A (en) | Il-17 binding compounds and medical uses thereof | |
| NZ600690A (en) | Fkbp-l and uses thereof | |
| NZ597154A (en) | Immunogenic compositions of staphylococcus aureus antigens | |
| MY192981A (en) | Cyclosporine analogue molecules modified at amino acid 1 and 3 | |
| NZ603813A (en) | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases | |
| NZ602693A (en) | Immunogenic proteins and compositions for the treatment and prevention of streptococcus agalactiae | |
| MX2014001375A (es) | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. | |
| NZ602170A (en) | Modified leptin polypeptides and their uses | |
| NZ597306A (en) | Mesenchymal stem cell differentiation | |
| NZ593893A (en) | Gene encoding human glucokinase mutant, enzyme encoded by the same, recombinant vectors and hosts, pharmaceutical compositions and uses thereof, methods for treating and preventing diseases | |
| NZ596660A (en) | Dig-5 insecticidal cry toxins | |
| MX2008009493A (es) | Peptido novedoso y uso del mismo. | |
| NZ701125A (en) | Improved chymosine enzyme variants | |
| NZ628756A (en) | Immunogens for hiv vaccination | |
| NZ601488A (en) | Immunogenic proteins and compositions | |
| NZ610732A (en) | Novel angiotensin type 2 (at2) receptor agonists and uses thereof | |
| NZ596313A (en) | Pharmaceutical compositions containing antifungal peptides | |
| PH12012502323A1 (en) | Levoisovalerylspiramycin i, ii or iii, preparations, preparation methods and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 23 MAR 2017 BY IN-LEGAL LIMITED Effective date: 20140829 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 23 MAR 2018 BY COMPUTER PACKAGES INC Effective date: 20170302 |
|
| LAPS | Patent lapsed |